Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07223931 · ClinicalTrials.gov registry record
Validating Dozee for Contactless Monitoring of Heart, Breathing, and Movemen
A clinical trial of No Specific Medical Conditions or Disease States and No Specific Conditions, sponsored by Turtle Shell Technologies Pvt..
- Recruiting
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT07223931: Recruiting study of No Specific Medical Conditions or Disease States and No Specific Conditions, sponsored by Turtle Shell Technologies Pvt..
NCT07223931 is a study of No Specific Medical Conditions or Disease States and No Specific Conditions that is actively recruiting participants, run by Turtle Shell Technologies Pvt.. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07223931, a study of No Specific Medical Conditions or Disease States and No Specific Conditions, is actively recruiting participants, sponsored by Turtle Shell Technologies Pvt..
- RECRUITING
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The Dozee VS system (K221555) is a contactless device that tracks heart rate and breathing rate using a sensor sheet placed under the mattress. It captures body vibrations and converts them into vital signs, which can be monitored remotely in real time. The system also supports add-ons like a blood pressure cuff, pulse oximeter, and thermometer, offering a complete monitoring solution. This study aims to validate the updated AI-powered heart rate and improved breathing rate algorithms across different sensor sheet types to confirm clinical accuracy
Primary Outcome
Heart Rate collected at 1 Min intervals from gold standard and Dozee. Mean Absolute Error (MAE) of the Dozee Heart Rate will be calculated.
Conditions Studied
Interventions
- DEVICE Device: Telemetry monitoring
Study Locations (1)
Texas
- ERA Health Research - Midland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-09-16 |
| Est. Completion | 2025-12-31 |
What NCT07223931 shows while recruiting
NCT07223931 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 2 conditions, with No Specific Medical Conditions or Disease States appearing as the primary indexed condition, and to 1 intervention - of which Device: Telemetry monitoring is the first listed.
NCT07223931 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT07223931 about?
NCT07223931 is a clinical study titled "Validating Dozee for Contactless Monitoring of Heart, Breathing, and Movemen". The Dozee VS system (K221555) is a contactless device that tracks heart rate and breathing rate using a sensor sheet placed under the mattress. It captures body vibrations and converts them into vital signs, which can be monitored remotely in real time. The system also supports add-ons like a blood ...
What is the current status of trial NCT07223931?
This trial is currently recruiting. The enrollment target is 60 participants. The study started on 2025-09-16. Estimated completion is 2025-12-31.
What conditions does trial NCT07223931 study?
This clinical trial studies the following conditions: No Specific Medical Conditions or Disease States, No Specific Conditions.
What interventions are being tested in trial NCT07223931?
The interventions under investigation include: Device: Telemetry monitoring (DEVICE).
Who is sponsoring clinical trial NCT07223931?
This trial is sponsored by Turtle Shell Technologies Pvt., which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07223931 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI